Background Image
Table of Contents Table of Contents
Previous Page  2 / 68 Next Page
Information
Show Menu
Previous Page 2 / 68 Next Page
Page Background

CARVEDILOL:

- is indicated

twice daily

for

mild to moderate stable

symptomatic congestive

heart failure

- is indicated

once daily

for

essential mild to moderate

hypertension

-

has a positive effect

on metabolic parameters.

1

RESTORE

cardiac function

Carvetrend 6,25 mg.

Each tablet contains 6,25 mg carvedilol. Reg. No.: RSA S3 37/7.1.3/0276 NAM NS2 08/7.1.3/0105 BOT S2 BOT1101790.

Carvetrend 12,5 mg.

Each tablet contains 12,5 mg carvedilol. Reg. No.: RSA S3

37/7.1.3/0277 NAM NS2 08/7.1.3/0104 BOT S2 BOT1101791.

Carvetrend 25 mg.

Each tablet contains 25 mg carvedilol. Reg. No.: RSA S3 37/7.1.3/0278 NAM NS2 08/7.1.3/0103 BOT S2 BOT1101792. For full prescribing

information, refer to the package insert approved by the Medicines Control Council, 16 September 2004.

1)

Panagiotis C Stafylas, Pantelis A Sarafidis. Carvedilol in hypertension treatment. Vascular Health and Risk Management

2008;4(1):23-30.

CDC81/04/2015.

C A R V E D I L O L

6,25 mg 12,5 mg 25 mg

ß

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Tel

021 707 7000

Fax

021 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

A Lupin Group Company